Search & Analyze
Popular Searches
Krishna Institute of Medical Sciences Ltd
Healthcare₹793.801.17%
24 Jul, 4:01 PM
CMP₹793.80
Mkt Cap₹32.84K Cr
P/E136.03
P/B8.76
ROE20.92%
52W High₹858.15
52W Low₹575.55
Customise metrics bar
Sector Overview
HealthcareHospital & Healthcare Services
Krishna Institute of Medical Sciences Ltd operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.
Corporate Actions
Board Meeting2026-06-10 Inter alia, to consider and approve:- (1) the proposal for raising of funds by way of issuance of one or more instrument(s) / securities which may include equity shares, fully convertible warrants and/or any other eligible securities (convertible / non-convertible) and / or any combinations of securities thereof through permissible modes, including but not limited to a preferential issue on a private placement basis or through any other permissible mode and / or combination thereof as may be considered appropriate
Board Meeting2026-05-06 Audited Results
Ex Rights2026-03-11Rights Issue Inter alia considered and approved the following: 1. Raising of funds by way of a qualified institutions placement and/or any other permissible mode or any combination thereof to investors through issuance of equity shares Raising of funds for an aggregate amount of up to and not exceeding ?1,500 Crores (Rupees fifteen hundred crores only) by way of issuance of equity shares, in one or more tranches by way of one or more Qualified Institutions Placements (?QIP?) and/or any other permissible mode or any combination thereof in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (each as amended), or through any other permissible mode or any combination thereof, in such manner, and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company and such other regulatory and statutory approvals as may be required and determination of the issue price. In order to give effect to the above, the Board has authorized the Finance & Investment Committee of the Board to, inter-alia, decide the terms and conditions of the proposed fund raise; 2. Approval of issue of postal ballot notice : The Board has approved the Postal Ballot Notice for seeking Members? approval by way of postal ballot in respect of the aforesaid matters. The Notice will be circulated to the Members in due course, in accordance with applicable laws
Rights Announcement2026-03-06Rights Issue & Right Issue of Equity Shares & Inter alia, to consider and approve and evaluate the proposal for raising of funds by way of issuance of equity shares, in one or more tranches by way of one or more Qualified Institutions Placements ( QIP ) and/or rights issue in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (each as amended), or through any other permissible mode or any combination thereof, in such manner, and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company and such other regulatory and statutory approvals as may be required, if any, as may be required and determination of the issue price.
Board Meeting2026-03-06 Rights Issue & Right Issue of Equity Shares & Inter alia, to consider and approve and evaluate the proposal for raising of funds by way of issuance of equity shares, in one or more tranches by way of one or more Qualified Institutions Placements ( QIP ) and/or rights issue in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (each as amended), or through any other permissible mode or any combination thereof, in such manner, and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company and such other regulatory and statutory approvals as may be required, if any, as may be required and determination of the issue price.
KIMS
₹793.80
+1.17%